human clinical trials ongoing as of 2026 Search volume: 165,000 monthly US searches most searched non-weight-loss peptide Legal status: Category 1 compounding (legal under physician prescription, as of February 2026) Administration: Subcutaneous injection or oral/sublingual (gut applications) An honest note on the evidence: The majority of BPC-157 research has been conducted in animal models rats and mice primarily
[2] The Phase 3a REDEFINE 2 trial then tested once-weekly CagriSema (cagrilintide 2.4 mg plus semaglutide 2.4 mg) against placebo in 1,206 adults with obesity and type 2 diabetes over 68 weeks, reporting a mean bodyweight change of 13.7% versus 3.4% for placebo
Not as a beauty hack, but as a serious, science-backed tool for detox, resilience, and some much-needed restoration
Astaxanthin is a xanthophyll carotenoid produced by microalgae ( Haematococcus pluvialis )
Weight loss plateaus, return of appetite, increased blood sugar readings, and decreased metabolic effects can all signal that your medication has lost potency